Urocortin does not reduce the renal injury and dysfunction caused by experimental ischaemia/reperfusion

European Journal of Pharmacology

Volumn 496, Issue 1, 2004, Pages 175-180

  Patel, Nimesh S A ^a   Collin, Marika ^a   Thiemermann, Christoph ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Kidney; Renal dysfunction; Reperfusion injury; Urocortin

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CREATININE; UREA; UROCORTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; DRUG EFFECT; KIDNEY ARTERY STENOSIS; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY PERFUSION; MALE; MICTURITION; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; TIME; UREA BLOOD LEVEL;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; CREATININE; ISCHEMIA; KIDNEY; MALE; METABOLIC CLEARANCE RATE; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 3543144947     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.06.008     Document Type: Article

References (26)

1. Abdelrahman A.M., Pang C.C. Regional haemodynamic effects of urocortin in the anaesthetized rat. Eur. J. Pharmacol. 466:2003;317-321
2. Brar B.K., Jonassen A.K., Stephanou A., Santilli G., Railson J., Knight R.A., Yellon D.M., Latchman D.S. Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway. J. Biol. Chem. 275:2000;8508-8514
3. Brar B.K., Stephanou A., Knight R., Latchman D.S. Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death. J. Mol. Cell Cardiol. 34:2002;483-492
4. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell. 96:1999;857-868
5. Chatterjee P.K., Cuzzocrea S., Brown P.A., Zacharowski K., Stewart K.N., Mota-Filipe H., Thiemermann C. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int. 58:2000;658-673
6. Chatterjee P.K., Zacharowski K., Cuzzocrea S., Otto M., Thiemermann C. Inhibitors of poly(ADP-ribose) synthetase reduce renal ischemia-reperfusion injury in the anesthetized rat in vivo. FASEB J. 14:2000;641-651
7. Chatterjee P.K., Patel N.S.A., Sivarajah A., Kvale E.O., Dugo L., Cuzzocrea S., Brown P.A., Stewart K.N., Mota-Filipe H., Britti D., Yaqoob M.M., Thiemermann C. GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury. Kidney Int. 63:2003;853-865
8. Datta S.R., Brunet A., Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 13:1999;2905-2927
9. Dautzenberg F.M., Hauger R.L. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol. Sci. 23:2002;71-77
10. Kelly K.J., Molitoris B.A. Acute renal failure in the new millennium: time to consider combination therapy. Semin. Nephrol. 20:2000;4-19
11. Kennedy S.G., Kandel E.S., Cross T.K., Hay N. Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol. Cell. Biol. 19:1999;5800-5810
12. Lameire N., Vanholder R. Pathophysiologic features and prevention of human and experimental acute tubular necrosis. J. Am. Soc. Nephrol. 12(Suppl 17):2001;S20-S32
13. Latchman D.S. Urocortin. Int. J. Biochem. Cell Biol. 34:2002;907-910
14. Lieberthal W., Levine J.S. Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am. J. Physiol. 271:1996;F477-F488
15. Muller C., Dunschede F., Koch E., Vollmar A.M., Kiemer A.K. Alpha-lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway. Am. J. Physiol.: Gasterointest. Liver Physiol. 285:2003;G769-G778
16. Noshita N., Lewen A., Sugawara T., Chan P.H. Evidence of phosphorylation of Akt and neuronal survival after transient focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 21:2001;1442-1450
17. Okosi A., Brar B.K., Chan M., D'Souza L., Smith E., Stephanou A., Latchman D.S., Chowdrey H.S., Knight R.A. Expression and protective effects of urocortin in cardiac myocytes. Neuropeptides. 32:1998;167-171
18. Ozes O.N., Mayo L.D., Gustin J.A., Pfeffer S.R., Pfeffer L.M., Donner D.B. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature. 401:1999;82-85
19. Paller M.S. Pathophysiologic mechanisms of acute renal failure. Goldstein R.S. Mechanism of Injury in Renal Disease and Toxicity. 1994;3-13 CRC Press, Ann Arbor, USA
20. Schulman D., Latchman D.S., Yellon D.M. Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway. Am. J. Physiol, Heart Circ. Physiol. 283:2002;H1481-H1488
21. Sheridan A.M., Bonventre J.V. Pathophysiology of ischemic acute renal failure. Contrib. Nephrol. 2001;7-21
22. Shimamura H., Terada Y., Okado T., Tanaka H., Inoshita S., Sasaki S. The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-kappa B and Bad. J. Am. Soc. Nephrol. 14:2003;1427-1434
23. Sivarajah A., Chatterjee P.K., Patel N.S.A., Todorovic Z., Hattori Y., Brown P.A.J., Stewart K.N., Mota-Filipe H., Cuzzocrea S., Thiemermann C. Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia/reperfusion injury. Am. J. Nephrol. 23:2003;267-276
24. Su B., Karin M. Mitogen-activated protein kinase cascades and regulation of gene expression. Curr. Opin. Immunol. 8:1996;402-411
25. Thiemermann C., Patel N.S.A., Kvale E.O., Cockerill G.W., Brown P.A.J., Stewart K.N., Cuzzocrea S., Britti D., Mota-Filipe H., Chatterjee P.K. High density lipoprotein (HDL) reduces renal ischemia/reperfusion injury. J. Am. Soc. Nephrol. 14:2003;1833-1843
26. Weight S.C., Bell P.R., Nicholson M.L. Renal ischaemia-reperfusion injury. Br. J. Surg. 83:1996;162-170